Transapical aortic valve implantation: first 325 patients in a single center




Background


Transapical aortic valve implantation is a novel therapeutic approach in high-risk patients with severe aortic stenosis. We report a single-center experience during and after the learning curve for establishing this new method.




Methods


Between April 2008 and December 2010, 325 patients [mean age, 79±9 years (range, 28–99 years)] were treated by transapical aortic valve implantation. The mean logistic euroSCORE for the whole group was 38±19% (range, 5%–97%). No patient was refused regardless of comorbidities. Nineteen patients were in cardiogenic shock. Planned additional procedures during valve implantation were performed in 45 patients (elective coronary stents in 33 patients, tricuspid valve repair in 2, ASD II closure in 1, miscellaneous in 9). Cardiopulmonary bypass was used in 18 patients (13 elective, 5 emergency).

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Coronary stenting with MGuard: extended follow-up of first human trial
  2. Understanding the impact of drug-eluting stent on vascular function and the nitric oxide pathway genes using a pig coronary artery stent implantation model
  3. Statin improves outcome of patients presenting with first acute myocardial infarction
  4. Definite stent thrombosis: a 2-center New Zealand registry

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Transapical aortic valve implantation: first 325 patients in a single center

Full access? Get Clinical Tree
Get Clinical Tree app for offline access